Genetic testing for von Hippel-Lindau disease

Genetic testing for von Hippel-Lindau disease - Genetic testing for von Hippel-Lindau disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000002694

Enrollment

100

Registered

2009-11-01

Start date

2009-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

von Hippel-Lindau (VHL) disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. patients clinically diagnosed as VHL disease 2. presymptomatic members of VHL families 3. patients suspected VHL disease

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
germline mutation detection for von Hippel-Lindau disease (VHL) gene	—

Secondary

Measure	Time frame
optimal patient follow-up based on the phenotype/genotype correlation study	—

Countries

Japan

Contacts

Public ContactMasahiro YAO

Yokohama City University Graduate School of Medicine Urology and Molecular Genetics

masayao@med.yokohama-cu.ac.jp045-787-2679

Outcome results